{"id":"https://genegraph.clinicalgenome.org/r/4487c035-49cb-4a14-84de-e914473001e2v1.0","type":"EvidenceStrengthAssertion","dc:description":"Spermatogenic failure 38 (SPGF38) is one of many types of spermatogenic failure characterized by asthenozoospermia and associated with variants in a single gene. SPGF38 phenotypes include male infertility due to morphologic abnormalities of the flagella (MMAF) such as shortness, irregular shape, coiling of the tail, and reduced sperm count. Structural analysis of affected flagella have revealed absent central pair complexes, loss of the circular formation of the microtubules (9+2 arrangement), and other structural abnormalities (PMID:30686508).\n\n*ARMC2* was first reported in relation to autosomal recessive spermatogenic failure 38 in 2019 (Coutton et al., PMID: 30686508). After a thorough literature search, no patients were found to be published in association with PCD, so *ARMC2* was only curated in association with SPGF38. \n\nIn this curation, 7 variants (1 missense, 3 nonsense, 2 frameshift, 1 splice site) that have been reported in 7 probands in 3 publications (PMIDs: 30686508, 35543806) are included. All reported probands were homozygous, with 3 families reported as consanguineous. There was one missense variant reported (c.2279T>A, p.Ile760Asn). Immunostaining or RNA analysis could not be performed on the patientâ€™s sperm to verify the impact of the missense change due to lack of a biological sample (PMID:30686508). There is also a splice site variant included in this curation, which the authors confirmed to skip exon 8 and result in an early termination codon in exon 9 (18 exons total) at the RNA level (PMID:30686508). The other 5 variants were predicted null variants which formed a stop codon upstream of the last 50 base pairs of the penultimate exon, and are therefore expected to undergo nonsense-mediated decay. The mechanism of pathogenicity appears to be LOF. \n\nThis gene-disease relationship is also supported by expression studies, biochemical evidence, functional assays, and animal models (PMIDs: 30686508, 34982025, 23715323). GTEx expression data revealed increased expression in the testis compared to other tissues in unaffected individuals, which is consistent with the SPGF38 phenotype (PMID:23715323). Tagged *ARMC2* protein was found to be upregulated in regenerating chlamydomonas flagella compared to fully grown flagella, which supports the biochemical role of *ARMC2* in axonemal assembly (PMID: 34982025). Functional alteration of patient sperm cells was observed through the absence of SPAG6, a known marker of the central pair complex. This supports the suspected role of *ARMC2* mutations in contributing to the absent central pair complex flagellar phenotype (PMID:30686508). A chlamydomonas model demonstrates flagellar immotiltiy (0% velocity) similar to human patients with SPGF38. Additionally, the *armc2/pf27* mutants also had radial spokes limited to the proximal region of the flagella, which is consistent with the structural defects seen in flagellar cross-sections of patients (PMID:34982025). The immotility and mislocalized radial spoke phenotypes seen in the *armc2/pf27* null chlamydomonas model were rescued using a wild-type copy of chlamydomonas *ARMC2* (PMID:34982025). Finally, a mouse model generated using the CRISPR-Cas9 system recapitulated the male infertility, MMAF (short, coiled, or thick), and reduced sperm count phenotypes seen in SPGF38 patients (PMID:30686508).\n\nIn summary, *ARMC2* is definitively associated with autosomal recessive spermatogenic failure 38. This has been repeatedly demonstrated in both research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Motile Ciliopathy GCEP on the meeting date 5/10/2023 (SOP Version [9]).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/4487c035-49cb-4a14-84de-e914473001e2","GCISnapshot":"https://genegraph.clinicalgenome.org/r/aef0ad23-4568-4ef7-94e9-557981bfbe6c","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/aef0ad23-4568-4ef7-94e9-557981bfbe6c_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10102","date":"2023-05-10T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/aef0ad23-4568-4ef7-94e9-557981bfbe6c_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10102","date":"2023-06-07T17:48:00.554Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aef0ad23-4568-4ef7-94e9-557981bfbe6c_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aed8e770-8b7e-486d-80bb-eb0dea536411_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d871603a-c3e4-4a2a-a826-3a84eba8bffb","type":"EvidenceLine","dc:description":"This proband was downscored for homozygosity.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d871603a-c3e4-4a2a-a826-3a84eba8bffb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30686508","allele":{"id":"https://genegraph.clinicalgenome.org/r/87af6586-5aae-44f4-85cd-e3606be9a9ff","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032131.6(ARMC2):c.1284_1288del (p.Lys428AsnfsTer3)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913189867"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/aed8e770-8b7e-486d-80bb-eb0dea536411","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30686508","rdfs:label":"Coutton_2019_ARMC2_4","allele":{"id":"https://genegraph.clinicalgenome.org/r/87af6586-5aae-44f4-85cd-e3606be9a9ff"},"detectionMethod":"WES + Sanger. Other MMAF genes were specifically analyzed (DNAH1, CFAP43, CFAP44, CFAP69, FSIP2, WDR66) and confirmed not to contain any homozygous deleterious variants. \n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0012864","obo:HP_0012207","obo:HP_0003251"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d871603a-c3e4-4a2a-a826-3a84eba8bffb_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d80dc445-d637-44d5-9d6e-18e8b8c4b871_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8bda426-8cd5-463b-aa22-513cbf2b43aa","type":"EvidenceLine","dc:description":"This proband was downscored for homozygosity.","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8bda426-8cd5-463b-aa22-513cbf2b43aa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30686508","allele":{"id":"https://genegraph.clinicalgenome.org/r/6ade98c3-50e4-4050-bfc9-96c673aba794","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032131.6(ARMC2):c.2279T>A (p.Ile760Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA365183865"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d80dc445-d637-44d5-9d6e-18e8b8c4b871","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30686508","rdfs:label":"Coutton_2019_ARMC2_2","allele":{"id":"https://genegraph.clinicalgenome.org/r/6ade98c3-50e4-4050-bfc9-96c673aba794"},"detectionMethod":"WES + Sanger. Other MMAF genes were specifically analyzed (DNAH1, CFAP43, CFAP44, CFAP69, FSIP2, WDR66) and confirmed not to contain any homozygous deleterious variants. \n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0012207","obo:HP_0012864","obo:HP_0003251"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e8bda426-8cd5-463b-aa22-513cbf2b43aa_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/481f4f99-1479-4c4f-b53f-19a2d6e06ef8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d85088f7-2ec6-4206-9fbd-394926746fcb","type":"EvidenceLine","dc:description":"This variant was downscored due to reported consanguinity. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d85088f7-2ec6-4206-9fbd-394926746fcb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30686508","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc90665f-d87c-4672-a0b0-f7a5948fe1d1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032131.6(ARMC2):c.421C>T (p.Gln141Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA365345520"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/481f4f99-1479-4c4f-b53f-19a2d6e06ef8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30686508","rdfs:label":"Coutton_2019_ARMC2_5","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc90665f-d87c-4672-a0b0-f7a5948fe1d1"},"detectionMethod":"WES + Sanger. Other MMAF genes were specifically analyzed (DNAH1, CFAP43, CFAP44, CFAP69, FSIP2, WDR66) and confirmed not to contain any homozygous deleterious variants. ","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0012207","obo:HP_0012864","obo:HP_0003251"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d85088f7-2ec6-4206-9fbd-394926746fcb_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8b0d9993-7c9a-42fc-92ba-ff57cb88b35a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7757602-559a-45ca-8a1c-182d3a434bfd","type":"EvidenceLine","dc:description":"This variant was downscored due to homozygosity and consanguinity. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7757602-559a-45ca-8a1c-182d3a434bfd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34493464","allele":{"id":"https://genegraph.clinicalgenome.org/r/cc42e6a0-a10e-440d-bef5-a38005b1ceed","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032131.6(ARMC2):c.182C>G (p.Ser61Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA365344224"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/8b0d9993-7c9a-42fc-92ba-ff57cb88b35a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34493464","rdfs:label":"Khan_2021_IV:2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":31,"allele":{"id":"https://genegraph.clinicalgenome.org/r/cc42e6a0-a10e-440d-bef5-a38005b1ceed"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":" ","phenotypes":["obo:HP_0000798","obo:HP_0012864","obo:HP_0012207"],"previousTesting":true,"previousTestingDescription":"TEM analysis revealed disorganized axonemal structures and absence of CPCs\n","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c7757602-559a-45ca-8a1c-182d3a434bfd_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/8667305c-083f-4c25-a133-c2213ace8f12_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/18a2576e-5fbc-4321-8ba1-07d9a39a5b93","type":"EvidenceLine","dc:description":"This proband was downscored for homozygosity.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/18a2576e-5fbc-4321-8ba1-07d9a39a5b93_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30686508","allele":{"id":"https://genegraph.clinicalgenome.org/r/23d39823-4934-403d-aaf7-cf841f8838f7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032131.6(ARMC2):c.1023+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA365343831"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8667305c-083f-4c25-a133-c2213ace8f12","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30686508","rdfs:label":"Coutton_2019_ARMC2_1","allele":{"id":"https://genegraph.clinicalgenome.org/r/23d39823-4934-403d-aaf7-cf841f8838f7"},"detectionMethod":"WES + Sanger. Other MMAF genes were specifically analyzed (DNAH1, CFAP43, CFAP44, CFAP69, FSIP2, WDR66) and confirmed not to contain any homozygous deleterious variants. ","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0003251","obo:HP_0012864","obo:HP_0012207"],"previousTesting":true,"previousTestingDescription":"TEM revealed absent CPC","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/18a2576e-5fbc-4321-8ba1-07d9a39a5b93_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/df4acb3e-2d6d-4847-a983-592a918eb626_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f356772f-43f5-4266-8db3-794bc8b6dc0e","type":"EvidenceLine","dc:description":"This proband was downscored for homozygosity.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f356772f-43f5-4266-8db3-794bc8b6dc0e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30686508","allele":{"id":"https://genegraph.clinicalgenome.org/r/6e370823-464c-4c30-b485-99b80b87184a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032131.6(ARMC2):c.2353_2354del (p.Leu785MetfsTer5)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913190186"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/df4acb3e-2d6d-4847-a983-592a918eb626","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30686508","rdfs:label":"Coutton_2019_ARMC2_3","allele":{"id":"https://genegraph.clinicalgenome.org/r/6e370823-464c-4c30-b485-99b80b87184a"},"detectionMethod":"WES + Sanger. Other MMAF genes were specifically analyzed (DNAH1, CFAP43, CFAP44, CFAP69, FSIP2, WDR66) and confirmed not to contain any homozygous deleterious variants. \n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0012864","obo:HP_0003251","obo:HP_0012207"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f356772f-43f5-4266-8db3-794bc8b6dc0e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4f039eb6-18c7-400e-a574-ff7c4b38a47c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7420b09d-ad47-4290-9524-692ecf1a9d02","type":"EvidenceLine","dc:description":"This variant was downscored due to reported consanguinity. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7420b09d-ad47-4290-9524-692ecf1a9d02_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35543806","allele":{"id":"https://genegraph.clinicalgenome.org/r/a55893cf-e4fd-48d7-9a93-d395d8353dd6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032131.6(ARMC2):c.1759C>T (p.Arg587Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3950004"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4f039eb6-18c7-400e-a574-ff7c4b38a47c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35543806","rdfs:label":"Wang_2022_patient","allele":{"id":"https://genegraph.clinicalgenome.org/r/a55893cf-e4fd-48d7-9a93-d395d8353dd6"},"detectionMethod":"WES + Sanger. Analysis of other MMAF-associated genes (DNAH1, CFAP43, CFAP44, CFAP69, FSIP2, TTC21A,\nTTC29, and WDR66) revealed no notable findings. ","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0012864","obo:HP_0012207","obo:HP_0003251"],"previousTesting":true,"previousTestingDescription":"TEM revealed absence of CPC. ","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7420b09d-ad47-4290-9524-692ecf1a9d02_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11},{"id":"https://genegraph.clinicalgenome.org/r/aef0ad23-4568-4ef7-94e9-557981bfbe6c_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aef0ad23-4568-4ef7-94e9-557981bfbe6c_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c90d9fe1-1b30-4e5c-8afd-4b8137147e10","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/27a0efe4-42b3-48e4-aeeb-16ebd3184ebc","type":"Finding","dc:description":"male infertility, morphological abnormalities such as short, think or coiled flagella, and reduced sperm concentration are all seen in human patients with PCD 38. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30686508","rdfs:label":"Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/cab24d75-ca8b-4bbb-9981-63d6e70ab6e6","type":"EvidenceLine","dc:description":"This model was downscored due to the inability of the chlamydomonas model to demonstrate male infertility ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/424f898c-9e5d-4e9d-8777-d288d587040d","type":"Finding","dc:description":"Chlamydomonous armc2 mutants were immotile (swimming velocity of 0 micrometers/s). Furthermore, the armc2 mutants were unable to develop radial spokes at the distal end of the cilia. The observations of immotiility and the morphological abnormality due to radial spoke deficiency are consistent with the phenotypes seen in humans with spermatogenic failure 38 (infertility, immotile sperm, sperm morphological abnormalities). ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34982025","rdfs:label":"Chlamydomonas Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c04ae0b9-33f9-4322-af1b-eef3da63015a","type":"EvidenceLine","dc:description":"Rescue downscored due to inability to test infertility phenotype ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/76527a42-2f11-403b-ab7f-2c264fbf6ac4","type":"Finding","dc:description":"motility restored to 100% WT, localization of radial spokes restored along length of cilia. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34982025","rdfs:label":"Chlamydomonas rescue ","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/aef0ad23-4568-4ef7-94e9-557981bfbe6c_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71656cf1-19ae-4e90-b056-4b063ad0d9d0","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/92a96239-d5cf-47d7-887c-42a60a9b0423","type":"FunctionalAlteration","dc:description":"SPAG6 was absent in patient cells, suggesting that variants in ARMC2 can disturb cilia assembly and structure.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30686508","rdfs:label":"Functional Alteration in patient cells "}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/aef0ad23-4568-4ef7-94e9-557981bfbe6c_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/785c6f82-e8ab-42ed-ab93-26a21202c59b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd38230d-2234-4e33-9aed-2e0b1d4cad89","type":"Finding","dc:description":"The enrichment of ARMC2 in growing flagella is consistent with this gene having a prominent role in the assembly of flagellar structure. It follows that dysfunction in ARMC2 would result in spermatogenic failure. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34982025","rdfs:label":"ARMC2 enriched in growing flagella","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/37dd4aa2-ea6e-47c1-9b0a-dbc71a5d3375","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/927345b4-8e5a-4d99-8c67-e7729bd4fcd0","type":"Finding","dc:description":"GTEx data revealed highly increased ARMC2 expression in the testis, which is consistent with the spermatogenic failure 38 phenotype. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23715323","rdfs:label":"GTEx expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5}],"evidenceStrength":"Definitive","sequence":6333,"specifiedBy":"GeneValidityCriteria9","strengthScore":16,"subject":{"id":"https://genegraph.clinicalgenome.org/r/orf-auNrJZM","type":"GeneValidityProposition","disease":"obo:MONDO_0032748","gene":"hgnc:23045","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_aef0ad23-4568-4ef7-94e9-557981bfbe6c-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}